HIF-1α is a regulator of galectin-3 expression in the intervertebral disc

被引:88
|
作者
Zeng, Yan [1 ]
Danielson, Keith G.
Albert, Todd J.
Shapiro, Irving M.
Risbud, Makarand V.
机构
[1] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA
[2] Peking Univ Hosp 3, Dept Orthopaed Surg, Beijing, Peoples R China
关键词
intervertebral disc; nucleus pulposus; hypoxia inducible factor-1 alpha; galectin-3; survival factor;
D O I
10.1359/JBMR.070620
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The regulation of galectin-3 expression in skeletal tissues is not completely understood. Our studies indicate that HIF-1 alpha regulates galectin-3 expression by interacting with hypoxia regulatory elements in the promoter region. Finally, we show that galectin-3 serves a prosurvival role in the intervertebral disc. Introduction: Earlier reports indicated that galectin-3 (gal-3) is highly expressed in the epiphyseal growth plate cartilage and the intervertebral disc. Because these skeletal tissues have a limited vascular supply and the cells reside in a low O-2 environment, we determined if the oxemic status modulates gal-3 expression. Materials and Methods: Cells were cultured in normoxia (21% O-2) or hypoxia (2% O-2), and gal-3 expression and promoter activity were evaluated. Interaction of hypoxia inducible factor (HIF)-1 alpha with the gal-3 promoter was confirmed by gel shift and site-directed mutagenesis. Results: There was minimal oxygen-dependent change in HIF-1 alpha levels and no change in gal-3 expression and promoter activity in nucleus pulposus cells. In contrast, hypoxia induced gal-3 mRNA, protein, and promoter activity in HeLa cells and mouse embryonic fibroblasts (MEFs) from HIF-1 alpha wildtype but not HIF-1-null mice. To evaluate the importance of HIF-1 in regulation of gal-3 expression, we overexpressed HIF-1 alpha or constitutively active-HIF-1 alpha in null MEF. An increase in gal-3 promoter activity was observed in both normoxia and hypoxia. Similarly, suppression of HIF-1 alpha in nucleus pulposus cells, and wildtype MEF, using siRNA and pharmacological inhibitors resulted in suppression of gal-3 promoter activity and mRNA levels. Analysis of the gal-3 promoter indicated that it contained two hypoxia response elements (HREs). Gel-shift and chromatin immunoprecipitation analysis confirmed that there was binding of HIF-1 alpha to the gal-3 HRE. Furthermore, site-directed mutagenesis of HRE completely blocked hypoxic induction of gal-3 promoter activity. In nucleus pulposus cells, suppression of gal-3 expression promoted FasL-mediated apoptosis. Conclusions: Together, these studies showed that gal-3 is a HIF-1-regulated lectin that plays an important role in nucleus pulposus cell survival.
引用
收藏
页码:1851 / 1861
页数:11
相关论文
共 50 条
  • [41] Expression of galectin-1 and galectin-3 in renal cell carcinoma; immunohistochemical study
    Aboulhagag, Noha A.
    El-Deek, Heba E. M.
    Sherif, Mahmoud F.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 36 : 31 - 37
  • [42] Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer
    Julie Ellerhorst
    Patricia Troncoso
    Xiao-Chun Xu
    Jack Lee
    Reuben Lotan
    Urological Research, 1999, 27 : 362 - 367
  • [43] Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas
    François, C
    van Velthoven, R
    De Lathouwer, O
    Moreno, C
    Peltier, A
    Kaltner, H
    Salmon, I
    Gabius, HJ
    Danguy, A
    Decaestecker, C
    Kiss, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (02) : 194 - 203
  • [44] Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice
    Chaudhari, Aparna D.
    Gude, Rajiv P.
    Kalraiya, Rajiv D.
    Chiplunkar, Shubhada V.
    MOLECULAR IMMUNOLOGY, 2015, 68 (02) : 300 - 311
  • [45] Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer
    Ellerhorst, J
    Troncoso, P
    Xu, XC
    Lee, J
    Lotan, R
    UROLOGICAL RESEARCH, 1999, 27 (05): : 362 - 367
  • [46] Taloside Inhibitors of Galectin-1 and Galectin-3
    Collins, Patrick M.
    Oberg, Christopher T.
    Leffler, Hakon
    Nilsson, Ulf J.
    Blanchard, Helen
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (03) : 339 - 346
  • [47] Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets
    Pejnovic, Nada N.
    Pantic, Jelena M.
    Jovanovic, Ivan P.
    Radosavljevic, Gordana D.
    Djukic, Aleksandar Lj
    Arsenijevic, Nebojsa N.
    Lukic, Miodrag L.
    ADIPOCYTE, 2013, 2 (04) : 266 - 271
  • [48] Galectin-1 and galectin-3 in chronic pancreatitis
    Wang, L
    Friess, H
    Zhu, ZW
    Frigeri, L
    Zimmermann, A
    Korc, M
    Berberat, PO
    Büchler, MW
    LABORATORY INVESTIGATION, 2000, 80 (08) : 1233 - 1241
  • [49] Galectin-3 as a New Dynamic Regulator of the Spindle Pole Stability
    Magescas, J.
    Sengmanivong, L.
    Poirier, F.
    Delacour, D.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [50] Galectin-3: A Central Regulator of Chronic Inflammation and Tissue Fibrosis
    Henderson, Neil C.
    Mackinnon, Alison C.
    Rooney, Claire
    Sethi, Tariq
    GALECTINS AND DISEASE IMPLICATIONS FOR TARGETED THERAPEUTICS, 2012, 1115 : 377 - +